A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine

Cdk9 is a key elongation factor for RNA transcription and functions by phosphorylating the C-terminal domain of RNA polymerase II. Here we present direct evidence that cdk9 is important for cancer cell survival and describe the characterization of the potent cdk9 inhibitor CDKI-73 in primary human l...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Walsby, Elisabeth, Pratt, Guy, Shao, Hao, Abbas, Abdullah Y., Fischer, Peter M., Bradshaw, Tracey D., Brennan, Paul, Fegan, Chris, Wang, Shudong, Pepper, Chris
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2013
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3964214/
https://ncbi.nlm.nih.gov/pubmed/24495868
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk